Clinical Trial Update: Prevalence and Risk of Cataracts in Granulocyte Donors

View source ↗

Summary

This clinical trial update reports on the prevalence and risk of cataracts among granulocyte donors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Apheresis | Status: COMPLETED